Related Experiment Video
Updated: Jul 26, 2026

The Fastest Western in Town: A Contemporary Twist on the Classic Western Blot Analysis
Published on: February 5, 2014
The sartans are coming!
1MWEC, Glasgow, Scotland. 100344.1432@compuserve.com
Abstract:
The 3(rd) International Symposium on Angiotensin II Antagonism was held in London February 28-March 2, 2000, and was accompanied by a number of company-sponsored symposia discussing "sartan" drugs. The advent of these angiotensin II receptor antagonists in the 1990s was welcomed with much enthusiasm owing to their reduced side effect profiles in comparison with members of other classes of antihypertensive drugs. Losartan and valsartan had previously been combined successfully with hydrochlorothiazide. A new sartan combination--candesartan cilexetil + hydrochlorothiazide--was announced during the meeting and new clinical trial data were presented. There are a number of questions that still need answers with respect to the role of the sartans in areas other than hypertension; help in answering at least some of these questions should be provided soon by the results of several megastudies that are currently under way.
Related Concept Videos
Schemas
The Stanford Prison Experiment
Robbers Cave
SBAR I: Understanding the Concept
Standardized methods of communication have been developed to ensure that information is...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

